![George Fitzgerald](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
George Fitzgerald
Consejero General en Mytogen, Inc. .
Perfil
George Fitzgerald is Vice President of Regulatory and Quality Assurance for Mytogen, Inc. Previously, he was Director of Toxicology for Toxikon Corp.
and an Associate Director of the Dermatologic Oncology Department for the Dana Farber Cancer Institute.
Dr. Fitzgerald received a PhD from Purdue University.
Cargos activos de George Fitzgerald
Empresas | Cargo | Inicio |
---|---|---|
Mytogen, Inc.
![]() Mytogen, Inc. BiotechnologyHealth Technology Mytogen, Inc. provides healthcare services. It focuses on using myoblasts, stem cells that form muscle, to treat patients with cardiac indications such as congestive heart failure, a progressive deterioration of the heart muscle. The company was founded in 1990 and is headquartered in Los Angeles, CA. | Consejero General | - |
Antiguos cargos conocidos de George Fitzgerald.
Empresas | Cargo | Fin |
---|---|---|
Dana-Farber Cancer Institute, Inc.
![]() Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Formación de George Fitzgerald.
Purdue University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Mytogen, Inc.
![]() Mytogen, Inc. BiotechnologyHealth Technology Mytogen, Inc. provides healthcare services. It focuses on using myoblasts, stem cells that form muscle, to treat patients with cardiac indications such as congestive heart failure, a progressive deterioration of the heart muscle. The company was founded in 1990 and is headquartered in Los Angeles, CA. | Health Technology |
Dana-Farber Cancer Institute, Inc.
![]() Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Health Services |
- Bolsa de valores
- Insiders
- George Fitzgerald